期刊文献+

遗传性易栓症的研究进展 被引量:9

原文传递
导出
摘要 易栓症(thrombophilia)一词是由Egeberg于1965年通过对1例遗传性抗凝血酶-Ⅲ(antithrombin-Ⅲ,AT-Ⅲ)缺陷症的报道首先提出。易栓症不是单一疾病,而是指由于抗凝蛋白、凝血因子、纤溶蛋白等的遗传性或获得性缺陷,或存在获得性危险因素而容易发生血栓栓塞的疾病或状态。根据临床症状、体征及实验室检查,主要将易栓症分为两类:遗传性易栓症和获得性易栓症。
作者 邹虹 漆洪波
出处 《中华产科急救电子杂志》 2014年第2期59-62,共4页 Chinese Journal of Obstetric Emergency(Electronic Edition)
  • 相关文献

参考文献10

  • 1刘丽,贺立山,杨爽,王玉亮,黄繁嫱,穆红,江雁,肖萍,李敬东,李家增.遗传性蛋白S缺陷症一个新的基因突变[J].中华血液学杂志,2001,22(9):457-460. 被引量:14
  • 2Suneet P. Chauhan,Vincenzo Berghella,Maureen Sanderson,Everett F. Magann,John C. Morrison.American College of Obstetricians and Gynecologists practice bulletins: An overview[J].American Journal of Obstetrics and Gynecology.2006(6)
  • 3Adi Y. Weintraub,Eyal Sheiner,Amalia Levy,Ronit Yerushalmi,Moshe Mazor.Pregnancy complications in women with inherited thrombophilia[J].Archives of Gynecology and Obstetrics.2006(3)
  • 4Xipeng Wang,Zhengwen Ma,Qide Lin.Inherited thrombophilia in recurrent spontaneous abortion among Chinese women[J].International Journal of Gynecology and Obstetrics.2005(3)
  • 5Heather E.A. Howley,Mark Walker,Marc A. Rodger.A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction[J].American Journal of Obstetrics and Gynecology.2005(3)
  • 6贺立山.血液病家族新成员——易栓症[J].医学新知,2008,18(3):129-132. 被引量:5
  • 7Katarina A Bremme.Haemostatic changes in pregnancy[J].Best Practice & Research Clinical Haematology.2003(2)
  • 8林建华,沈瑶.妊娠期易栓症的处理[J].实用妇产科杂志,2009,25(3):142-144. 被引量:9
  • 9Edmund F. Funai.Inherited thrombophilia and preeclampsia: is the evidence beginning to congeal?[J].American Journal of Obstetrics and Gynecology.2009(2)
  • 10Yanhui Lu,Yanfen Zhao,Guozhang Liu,Xiaoling Wang,Zhihong Liu,Baiping Chen,Rutai Hui.Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population[J].Thrombosis Research.2002(1)

二级参考文献22

  • 1Peter R, Margaret R. Prescribing in pregnancy [M]. Anticoagulants in pregnancy.4st ed. Edition: UK,2008:56 - 71.
  • 2Greer IA, Nelson PC. Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a system review of safety and efficacy [J]. Blood ,2005,106(2):401-407.
  • 3CLASP(collaborative low-dose aspirin study in pregnancy) collaborative group. A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women [J]. lancet , 1994, 343(12) :619 - 629.
  • 4Tatewaki H,Thromb Haemost,1999年,82卷,65页
  • 5王鸿利,血栓病学,1998年,342页
  • 6Andersen B D,Thromb Haemost,1996年,76卷,143页
  • 7包承鑫,血栓与止血基础理论与临床(第2版),1996年,466页
  • 8Egeberg O. On the natural blood coagulation inhibitor system. Investigations of inhibitor factors based on antithrombin deficient blood[J].Thromb Diath Haemorrh, 1965,14(3-4):473-489.
  • 9Bertina R M, Koeleman B P, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C[J]. Nature, 1994,369(6475):64-67.
  • 10Tanaka Y, Ueda K, Ozawa T, et al. Intracellular accumulation of anti-thrombin Morioka C95R a novel mutation causing type Ⅰ anti-thrombin deficiency[J]. J Biol Chem,2002,27,277(52):51058-51067.

共引文献24

同被引文献67

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部